These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 21873107)

  • 21. New antibiotic agents in the pipeline and how they can help overcome microbial resistance.
    Gould IM; Bal AM
    Virulence; 2013 Feb; 4(2):185-91. PubMed ID: 23302792
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Forthcoming therapeutic perspectives for infections due to multidrug-resistant Gram-positive pathogens.
    Cornaglia G; Rossolini GM
    Clin Microbiol Infect; 2009 Mar; 15(3):218-23. PubMed ID: 19335369
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discovery research: the scientific challenge of finding new antibiotics.
    Livermore DM;
    J Antimicrob Chemother; 2011 Sep; 66(9):1941-4. PubMed ID: 21700626
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discovering new antimicrobial agents.
    Moellering RC
    Int J Antimicrob Agents; 2011 Jan; 37(1):2-9. PubMed ID: 21075608
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New antimicrobial agents on the horizon.
    Bush K; Pucci MJ
    Biochem Pharmacol; 2011 Dec; 82(11):1528-39. PubMed ID: 21798250
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combination drugs, an emerging option for antibacterial therapy.
    Cottarel G; Wierzbowski J
    Trends Biotechnol; 2007 Dec; 25(12):547-55. PubMed ID: 17997179
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The antibiotic development pipeline for multidrug‐resistant gram‐negative bacilli: current and future landscapes.
    Talbot GH
    Infect Control Hosp Epidemiol; 2010 Nov; 31 Suppl 1():S55-8. PubMed ID: 20929372
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A review of tigecycline--the first glycylcycline.
    Peterson LR
    Int J Antimicrob Agents; 2008 Dec; 32 Suppl 4():S215-22. PubMed ID: 19134522
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel Antibacterials: Alternatives to Traditional Antibiotics.
    Betts JW; Hornsey M; La Ragione RM
    Adv Microb Physiol; 2018; 73():123-169. PubMed ID: 30262108
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibiotic research and development: business as usual?
    Harbarth S; Theuretzbacher U; Hackett J;
    J Antimicrob Chemother; 2015; 70(6):1604-7. PubMed ID: 25673635
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discovery and antibacterial activity of glabramycin A-C from Neosartorya glabra by an antisense strategy.
    Jayasuriya H; Zink D; Basilio A; Vicente F; Collado J; Bills G; Goldman ML; Motyl M; Huber J; Dezeny G; Byrne K; Singh SB
    J Antibiot (Tokyo); 2009 May; 62(5):265-9. PubMed ID: 19343064
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The re-emerging role of microbial natural products in antibiotic discovery.
    Genilloud O
    Antonie Van Leeuwenhoek; 2014 Jul; 106(1):173-88. PubMed ID: 24923558
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibiotic research in the age of omics: from expression profiles to interspecies communication.
    Wecke T; Mascher T
    J Antimicrob Chemother; 2011 Dec; 66(12):2689-704. PubMed ID: 21930574
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Speculative strategies for new antibacterials: all roads should not lead to Rome.
    Shapiro S
    J Antibiot (Tokyo); 2013 Jul; 66(7):371-86. PubMed ID: 23612725
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The challenge of multidrug resistance: actual strategies in the development of novel antibacterials.
    Schmidt FR
    Appl Microbiol Biotechnol; 2004 Jan; 63(4):335-43. PubMed ID: 12802526
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibacterial research and development in the 21(st) Century--an industry perspective of the challenges.
    Thomson CJ; Power E; Ruebsamen-Waigmann H; Labischinski H
    Curr Opin Microbiol; 2004 Oct; 7(5):445-50. PubMed ID: 15451498
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Means of bacterial resistance].
    Moreillon P
    Rev Med Suisse Romande; 2000 Aug; 120(8):641-50. PubMed ID: 11028184
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dihydrofolate reductase inhibitors as antibacterial agents.
    Hawser S; Lociuro S; Islam K
    Biochem Pharmacol; 2006 Mar; 71(7):941-8. PubMed ID: 16359642
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Update on the antibacterial resistance crisis.
    Croft AC; D'Antoni AV; Terzulli SL
    Med Sci Monit; 2007 Jun; 13(6):RA103-18. PubMed ID: 17534243
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Coping with antibiotic resistance: the impending crisis.
    Gould IM
    Int J Antimicrob Agents; 2010 Nov; 36 Suppl 3():S1-2. PubMed ID: 21129626
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.